IUPAC Traditional

2-[2-(3,3-difluorocyclobutanecarbonyl)-octahydro-1H-pyrrolo[3,4-c]pyridin-5-yl]pyrazine

Compound number MolPort-047-700-096
Molecular weight 322.36
InChI key UOMUQBWTYLVHMK-UHFFFAOYSA-N
Molecular formula C16H20F2N4O
DMSO Solubility Unknown
SMILES FC1(F)CC(C1)C(=O)N1CC2CCN(CC2C1)c1cnccn1
Best offer
$138.00
Including direct shipping

Pack size:
1 mg
Shipping to:
United States
Lead time:
11 business days
Adjust Requirements

WuXi LabNetwork

Direct S&H to USA
80.00 USD
Catalog
Screening compound
Ships out
11 business days
Purity
91.82
Last updated
> 3 months ago
In warehouse
Unverified
Salt: FREE

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
1 mg
December 16, 2022
58.00 USD
2 mg
December 16, 2022
70.00 USD
3 mg
December 16, 2022
87.00 USD
10 mg
December 16, 2022
115.00 USD
15 mg
December 16, 2022
131.00 USD
20 mg
December 16, 2022
151.00 USD
25 mg
December 16, 2022
174.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-047-700-096

Names, Synonyms and 3rd Party Identifiers

InChI

InChI
1/C16H20F2N4O/c17-16(18)5-12(6-16)15(23)22-8-11-1-4-21(9-13(11)10-22)14-7-19-2-3-20-14/h2-3,7,11-13H,1,4-6,8-10H2
InChI key
UOMUQBWTYLVHMK-UHFFFAOYSA-N

Formula

Molecular formula
C16H20F2N4O
Molecular weight
322.36

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback